Hall Private Wealth Advisors
- SEC CIK
- 0001744091
- Latest filing
- Nov 15, 2023
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Hall Private Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q3 2023 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −705−100.0% | Sold out | Holders |
| Q1 2023 | 705 | $579.3K | 0.3% | −202−22.3% | Reduced | Holders |
| Q4 2022 | 907 | $654.4K | 0.4% | −7,233−88.9% | Reduced | Holders |
| Q3 2022 | 8,140 | $5.61M | 3.2% | +115+1.4% | Added | Holders |
| Q2 2022 | 8,025 | $4.74M | 2.7% | −2,637−24.7% | Reduced | Holders |
| Q1 2022 | 10,662 | $7.45M | 4.0% | +248+2.4% | Added | Holders |
| Q4 2021 | 10,414 | $6.58M | 4.1% | +64+0.6% | Added | Holders |
| Q3 2021 | 10,350 | $6.26M | 4.0% | +651+6.7% | Added | Holders |
| Q2 2021 | 9,699 | $5.42M | 3.5% | – | No prior filing | Holders |